🔴 FluoGuide is trading 7.19% down today after wider Q2 net loss

FluoGuide is trading at SEK 31.00 (-7.19%) as investors reassess its Q2 2026 results, which showed a wider DKK 12.819 million net loss versus DKK 8.947 million a year earlier.

• Operating cash flow was negative DKK 12.996 million, while cash and securities fell to DKK 49.8 million at June 30.
• Positive CT-005 results and CT-006 progress provided offsetting clinical momentum but did not outweigh loss expansion and funding concerns.